Back
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis.
K. Lamote, K. Nackaerts, JP. van Meerbeeck
Cancer Epidemiol. Biomarkers Prev. 2014 Jun;23(6):898-908.
PubMed: 24706728
Abstract
Past and present asbestos use will reflect in increasing numbers of mesothelioma cases in the next decades, diagnosed at a late stage and with a dismal prognosis. This stresses the need for early detection tools, which could improve patients' survival. Recently, breath analysis as a noninvasive and fast diagnostic tool has found its way into biomedical research. High-throughput breathomics uses spectrometric, chromatographic, and sensor techniques to diagnose asbestos-related pulmonary diseases based upon volatile organic compounds (VOC) in breath. This article reviews the state-of-the-art available breath analyzing techniques and provides the insight in the current use of VOCs as early diagnostic or prognostic biomarkers of mesothelioma to stimulate further research in this field. Cancer Epidemiol Biomarkers Prev; 23(6); 898-908. ©2014 AACR.
Associated compounds:
Compound Name
with link to compound page |
Structure | Number of references |
---|
No associated compound. |